The authors present a framework for the selection of immune aging biomarkers suitable for clinical trials in geroscience, alongside a translational roadmap for biomarker development to support the nex...

11th Edition Theme: Targeting Immune Aging | Time: 9:00am-1.15pm NYC; 14:00-18.15h Paris; 10:00am-2.15pm Sao Paulo

Tumor-associated macrophages (TAM) are among the most abundant immune cells in tumors and exhibit striking functional plasticity, enabling them to eit…

Tumor-associated macrophages (TAMs), which commonly express FOLR2 or TREM2, are enriched in solid tumors and keep the tumor microenvironment (TME) imm…

Over the past year, we have been fighting back against attacks on science and higher education. While we’ve made progress, many of us continue to be deeply impacted by cuts to federal grants and the p...

Keystone Symposia Scientific Advisory Board Member Dr. Shruti Naik leads in innovative effort to reshape the funding ecosystem in the State of New York to ensure the future of science and scientists i...

The request comes amid continuing uncertainty over federal funding, with research and thousands of jobs on the line.

Nature Reviews Nephrology - This Review discusses the latest advances in natural killer cell biology, including insights into population heterogeneity, and examines the roles of these innate...

Support a New York State Biomedical Institute for a Healthier, More Affordable Future

Dr. Shruti Naik is one of the immunologists in New York state behind NY-CURES, advocating for state investment in biomedical research.

Support a New York State Biomedical Institute for a Healthier, More Affordable Future

Alt: GIF of Jay-Z and Alicia Keys Empire State of Mind video with the words there 's nothing you can’t do

Support a New York State Biomedical Institute for a Healthier, More Affordable Future

Nature Reviews Clinical Oncology - A recent Nature article reports that mRNA vaccines against SARS-CoV-2 confer improved survival among patients with advanced-stage non-small-cell lung cancer or...

Nature Biomedical Engineering - This Review explores strategies for targeting and tracking RNA-LNP drugs, monitoring their in vivo behaviour, enhancing tissue-specific delivery, and using synthetic...

NY-CURES is working to advance bold, state-backed investment in biomedical research—on the scale of successful initiatives in California and Texas—to grow New York’s leadership in science, innovation, and health.

NY-CURES is working to advance bold, state-backed investment in biomedical research—on the scale of successful initiatives in California and Texas—to grow New York’s leadership in science, innovation, and health.

YouTube video by Concordia

An understanding of the molecular mechanisms promoting the generation of immunoregulatory and tumour-promoting monocytes and macrophages is key to breaking the cycle of tumour myelopoiesis and develop...

Forbes ranks the best employers to work for in each state. Discover companies with great benefits, excellent workplace culture, and high employee satisfaction.

For two decades, CIRM has been at the forefront of regenerative medicine, funding over 100 clinical trials and building the infrastructure that drives innovation in stem cell and gene therapies.

YouTube video by Forbes Breaking News

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like allergy drugs to fight it.

The U.S. government has sought to restrict immigration under the “America First” doctrine. These policies severely harm American science by stripping it of talent and eliminating a major driver of its...

Miriam Merad Receives France’s Prestigious Legion of Honor for Pioneering Immunology and Cancer Research New York, NY — In a landmark recognition of scientific excellence, Dr. Miriam Merad, MD, PhD